J&J's Esketamine for Depression Faces an FDA Panel Next Week - BioSpace

Submitted by Anonymous (not verified) on Fri, 02/08/2019 - 16:29

J&J's Esketamine for Depression Faces an FDA Panel Next Week  BioSpaceOn Feb. 12, a U.S. Food and Drug Administration (FDA) advisory committee will debate whether to recommend Johnson & Johnson's esketamine spray for major ...